SEC Form 4 · accession 0001628280-26-048498
Alignment Healthcare, Inc. · ALHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dawn Christine Maroney
Officer — President
Period of report
Jul 15, 2026
Accepted (ET)
Jul 16, 2026 · 4:54 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001832466
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2026 | M | 152,068 | $9.06 | A | 1,099,381 | D | |
| Common StockF2 | Jul 15, 2026 | S | 177,068 | $20.8281 | D | 922,313 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F3 | $9.06 | Jul 15, 2026 | M | 152,068 | D | — | Mar 8, 2032 | Common Stock | 152,068 | 0 | D |
Explanation of responses
- F1Date of adoption of Rule 10b5-1 plan: 3/13/26
- F2The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- F3Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.